金吾财讯 | 制药企业普遍转升，吉利德科学(GILD)涨5.57%，默沙东(MRK)涨4.4%，辉瑞(PFE)、艾伯维公司(ABBV)涨近3%，施贵宝(BMY)涨近2%。当地时间5月11日，美国总统特朗普表示，他将于当地时间12日签署行政令，让美国的处方药和医药产品价格几乎立即降低30%至80%。同时，他称，美国将实施“最惠国”政策，“即美国支付的价格将与世界上支付价格最低的国家相同”。一位白宫官员在周一上午的媒体电话会上表示："我们不认为此举会挫伤药企的创新动力。"他指出，随着其他国家承担更合理的药价份额，外国将开始为研发成本支付"公平比例"。该官员进一步解释，"目前药企在美国赚取的利润已远超所需，因此他们愿意以略高于边际成本的价格向其他国家销售，导致美国消费者承担了创新的主要负担。""新政并非剥夺药企的盈利能力，而是推动其与各国达成与其价值匹配的协议。"
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.